Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

0.4279
BATS BZX Real-Time Price
As of 10:35am ET
 +0.011 / +2.64%
Today’s Change
0.35
Today|||52-Week Range
5.19
-75.12%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close0.42
Today’s open0.43
Day’s range0.42 - 0.43
Volume7,580
Average volume (3 months)2,178,331
Market cap$60.7M
Dividend yield--
Data as of 10:35am ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-6.25%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...-0.23-7.08%
AKAOAchaogen Inc+0.09+2.87%
RNNRexahn Pharmaceutica...+0.01+3.49%
MSTXMast Therapeutics In...+0.01+2.65%
Data as of 10:36am ET, 05/31/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Inside Director
Michael A. Narachi
Chief Commercial Officer &
Executive VP
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers

Search for Jobs